Market Overview

UPDATE: D.A. Davidson Decreases Price Target on Team Inc

Related TISI
D.A. Davidson & Co. Sees Growth Outlook For Team
Medical Action Industries Leads Healthcare Sector; Aerie Pharmaceutical Meets Clinical Endpoints

In a report released Monday, analyst Tristan Richardson of D.A. Davidson and Company announces a price target trim on Team, Inc (NYSE: TISI) from $48 to $45, keeping the Neutral rating.

Richardson notes, "We are reducing our fiscal Q3 2014 projections to incorporate weaker productivity than we would normally expect in a seasonally weaker quarter in each of the company's segments: Mechanical, Inspection and Quest. Some of this work could be 'recouped' in future periods; however, the timing and magnitude of 'catch up' work is difficult to predict."

The reason listed for the decreased productivity has been the same story for most companies, weather. Poor weather conditions have yielded work delay and office closures across the nation.

TISI closed Friday at $44.68 and opened back up Monday at $44.50.

Latest Ratings for TISI

DateFirmActionFromTo
Jan 2014Johnson RiceDowngradesOverweightEqual-weight
Jan 2014DA DavidsonMaintainsNeutral
Oct 2013BB&T CapitalUpgradesHoldBuy

View More Analyst Ratings for TISI
View the Latest Analyst Ratings

Posted-In: D.A. DavidsonPrice Target Analyst Ratings

 

Related Articles (TISI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters